Experience with combination of nimotuzumab and intensity-modulated radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.
about
A retrospective paired study: efficacy and toxicity of nimotuzumab versus cisplatin concurrent with radiotherapy in nasopharyngeal carcinoma.Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma.Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: preliminary results from a phase II clinical trial.Concurrent Chemoradiotherapy with or without Anti-EGFR-Targeted Treatment for Stage II-IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow-up.Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab.Efficacy and safety of nimotuzumab with neoadjuvant chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma.Intensity-modulated radiotherapy plus nimotuzumab with or without concurrent chemotherapy for patients with locally advanced nasopharyngeal carcinoma.Treatment Outcomes of 257 Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Nimotuzumab Plus Intensity-Modulated Radiotherapy with or without Chemotherapy: A Single-Institution Experience.Efficacy and Safety of Nimotuzumab Plus Radiotherapy With or Without Cisplatin-Based Chemotherapy in an Elderly Patient Subgroup (Aged 60 and Older) With Nasopharyngeal Carcinoma.Additional induction chemotherapy to concurrent chemotherapy and intensity-modulated radiotherapy with or without nimotuzumab in first-line treatment for locoregionally advanced nasopharyngeal carcinoma: a propensity score matched analysis.
P2860
Q36220797-521678BF-EBA4-4471-AA68-2B2724AD2CC8Q37678950-DACAB34D-5C48-4D28-BB1F-8CAA779E3BDCQ37709310-7075F11D-F81E-4435-9108-6AC72B8C1C1AQ40109785-89C99C04-74BE-4698-8FC0-CBF1FB058DB7Q43119856-8ACFDD13-465D-48EA-A666-40C177F75566Q45357051-4376F992-D148-4874-B8A3-7D410362C8D7Q47102625-DA6B4BA4-0B66-4067-9A38-3AED15E6ED1BQ47301004-B220DDEC-C0BC-4289-828E-E9A0B42499EFQ50095911-384795C8-EBA3-4243-95AF-093D2D997E83Q50311224-488C36D6-B4D7-479B-A607-ED20460D89C7
P2860
Experience with combination of nimotuzumab and intensity-modulated radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Experience with combination of ...... nced nasopharyngeal carcinoma.
@ast
Experience with combination of ...... nced nasopharyngeal carcinoma.
@en
type
label
Experience with combination of ...... nced nasopharyngeal carcinoma.
@ast
Experience with combination of ...... nced nasopharyngeal carcinoma.
@en
prefLabel
Experience with combination of ...... nced nasopharyngeal carcinoma.
@ast
Experience with combination of ...... nced nasopharyngeal carcinoma.
@en
P2093
P2860
P356
P1476
Experience with combination of ...... anced nasopharyngeal carcinoma
@en
P2093
Cheng-Run Du
Fang-Fang Kong
Hong-Mei Ying
Jun-Jun Zhou
Rui-Ping Zhai
Shuang Huang
P2860
P304
P356
10.2147/OTT.S93238
P407
P50
P577
2015-11-18T00:00:00Z